Our team selected a , the industry standard for mAbs due to its ability to perform human-like glycosylation—a critical factor for drug efficacy.
The initial bioprocess for mAb-A production involved a traditional approach:
The team adjusts the buffer to 10 mM histidine (pH 6.0) with 150 mM arginine and 5% trehalose. This combination reduces viscosity to 8 cP at 120 mg/mL, allowing efficient TFF.
This article draws on industry best practices and publicly available case study methodologies. For a deeper dive, refer to the MabSelect and CHO-K1 technical manuals from Cytiva and Thermo Fisher.
A Mab A Case Study In Bioprocess Development Fix File
Our team selected a , the industry standard for mAbs due to its ability to perform human-like glycosylation—a critical factor for drug efficacy.
The initial bioprocess for mAb-A production involved a traditional approach: A Mab A Case Study In Bioprocess Development
The team adjusts the buffer to 10 mM histidine (pH 6.0) with 150 mM arginine and 5% trehalose. This combination reduces viscosity to 8 cP at 120 mg/mL, allowing efficient TFF. Our team selected a , the industry standard
This article draws on industry best practices and publicly available case study methodologies. For a deeper dive, refer to the MabSelect and CHO-K1 technical manuals from Cytiva and Thermo Fisher. Our team selected a